DeepTech Investor Summit

CompagOs AG

ETH spin-off

compagos.chZurich, Switzerland
37 profile visits

About

We develop biohardware for blood-based diagnostics that detects bone metastases and bone loss in cancer patients months before they become visible on imaging.

Our vision is to establish biohardware as the foundation for how bone biology is studied, therapies are developed, and diagnostics are designed.

Social media

Target Markets of your organization / Expansion or target markets of your spin-off

SwitzerlandUS

Industry Sector your organization invests in / Industry Sector of your Spin-off

Med Tech

Representatives

Co-Founder & CEO

CompagOs AG

Marketplace (1)

  • Investment

    Building the future of biohardware for bone health

    “We develop biohardware for blood-based diagnostics that detects bone metastases and bone loss months before clinical imaging sees them.

    • Pre-Seed
    • Bio Tech
    • Med Tech
    Author

    Co-Founder & CEO at CompagOs AG

    Zurich, Switzerland